We are live on
!
Find out more
HI
Human Investing Portfolio holdings
AUM
$771M
1-Year Est. Return
18.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+18.84%
3 Year Est. Return
+51.96%
5 Year Est. Return
+53.41%
10 Year Est. Return
–
AUM
$438M
AUM Growth
+$26.3M
(+6.4%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
2.42%
Top 10 Holdings %
Top 10 Hldgs %
69.8%
Holding
108
New
9
Increased
42
Reduced
45
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.14M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$1.42M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.14M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.09M |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$526K |
| 2 |
Broadcom
AVGO
|
+$487K |
| 3 |
Texas Instruments
TXN
|
+$459K |
| 4 |
Merck
MRK
|
+$433K |
| 5 |
AbbVie
ABBV
|
+$428K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.39% |
| 2 | Healthcare | 2.78% |
| 3 | Consumer Discretionary | 2.44% |
| 4 | Consumer Staples | 1% |
| 5 | Communication Services | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
BHP
BHP
$215B
| – | – |
-3,158
| Closed | -$200K |
|
102
Enphase Energy
ENPH
$4.96B
| – | – |
-994
| Closed | -$209K |
|
103
FMC
FMC
$1.34B
| – | – |
-1,908
| Closed | -$233K |
|
104
Lowe's Companies
LOW
$117B
| – | – |
-2,066
| Closed | -$413K |
|
105
Medifast
MED
$109M
| – | – |
-2,020
| Closed | -$209K |
|
106
ONE Gas
OGS
$4.87B
| – | – |
-3,745
| Closed | -$297K |
|
|
107
Ulta Beauty
ULTA
$22B
| – | – |
-964
| Closed | -$526K |
|
108
Viatris
VTRS
$20.4B
| – | – |
-10,838
| Closed | -$104K |
|
Similar funds
WI
CCA
PGA
SC
PA
BPIM
TCM
PC
Human Investing's Q2 2023 Portfolio in Review
As of Q2 2023, Human Investing held 108 positions worth $438M, up 6.4% from $412M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Human Investing's Q2 2023 filing shows 9 new, 42 increased, 45 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 34,715 shares worth $700K. The largest sale was Ulta Beauty, an estimated $526K.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Human Investing's largest Q2 2023 buy was iShares Core High Dividend ETF: 34,715 shares worth $700K.
- Human Investing added most to Vanguard S&P 500 ETF in Q2 2023, an estimated $3.14M increase.
- Human Investing's biggest Q2 2023 reduction was Broadcom, cutting an estimated $487K.
- Human Investing fully exited Ulta Beauty in Q2 2023, selling an estimated $526K.
- Human Investing's ten largest holdings make up 70% of its $438M portfolio in Q2 2023.
- Human Investing opened 9 new positions and closed 9 in Q2 2023.
- Human Investing's portfolio value rose 6.4% quarter-over-quarter to $438M.
Based on Human Investing's 13F filing for Q2 2023, filed 7 Aug 2023.